Corcept Therapeutics Incorporated shares owned by UBS Group
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.3M | 133k | 32.48 |
| 2023-09-30 | $1.9M | 69k | 27.25 |
| 2023-06-30 | $1.1M | 48k | 22.25 |
| 2023-03-31 | $746k | 34k | 21.66 |
| 2022-12-31 | $636k | 31k | 20.31 |
| 2022-09-30 | $850k | 33k | 25.64 |
| 2022-06-30 | $755k | 32k | 23.47 |
| 2022-03-31 | $5.4M | 243k | 22.29 |
| 2021-12-31 | $4.7M | 240k | 19.80 |
| 2021-09-30 | $741k | 38k | 19.69 |
| 2021-06-30 | $2.2M | 101k | 22.01 |
| 2021-03-31 | $989k | 42k | 23.80 |
| 2020-12-31 | $1.1M | 41k | 26.47 |
| 2020-09-30 | $731k | 42k | 17.40 |
| 2020-06-30 | $2.2M | 132k | 16.82 |
| 2020-03-31 | $3.8M | 318k | 11.89 |
| 2019-12-31 | $4.0M | 330k | 12.10 |
| 2019-09-30 | $2.2M | 154k | 14.13 |
| 2019-06-30 | $1.7M | 151k | 11.15 |
| 2019-03-31 | $802k | 68k | 11.75 |
| 2018-12-31 | $1.4M | 106k | 13.36 |
| 2018-09-30 | $837k | 60k | 14.05 |
| 2018-06-30 | $1.5M | 96k | 15.70 |
| 2018-03-31 | $905k | 55k | 16.42 |
| 2017-12-31 | $1.1M | 59k | 18.00 |
| 2017-09-30 | $1.5M | 76k | 19.30 |
| 2017-06-30 | $780k | 66k | 11.80 |
| 2017-03-31 | $754k | 69k | 10.97 |
| 2016-12-31 | $596k | 82k | 7.25 |
| 2016-09-30 | $464k | 71k | 6.50 |
| 2016-06-30 | $873k | 157k | 5.55 |
| 2016-03-31 | $527k | 112k | 4.69 |
| 2015-12-31 | $677k | 136k | 4.98 |
| 2015-09-30 | $406k | 112k | 3.62 |
| 2015-03-31 | $707k | 123k | 5.76 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated